Evidence map›Paper›PMID 39428565›Full record

ArticleEmerging infectious diseases2024

Invasive Group A Streptococcus Hypervirulent M1

Alyssa R Golden, Averil Griffith, Gregory J Tyrrell, Julianne V Kus, Allison McGeer, Marc-Christian Domingo, Jennifer Grant, Jessica Minion, Paul Van Caeseele, Guillaume Desnoyers and 7 more

Abstract readHistorical Article
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Tracing the recent evolution of Group AEmerging microbes & infections · 2026
    Review
  2. Predominance of M1European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Genomic analysis and clinical characteristics of a seasonal upsurge of Streptococcus pyogenes emm12.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Article
  5. Article
  6. Mortality Among Patients With Invasive Group A Streptococcal Infections Caused by the M1UK Lineage: A Retrospective Cohort Study in England and Wales.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  7. Article
  8. Additional biomarkers and emm types associated with group A streptococcal toxic shock syndrome: a Japanese nationwide observational study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Observational
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alyssa R Golden
Averil Griffith
Gregory J Tyrrell
Julianne V Kus
Allison McGeer
Marc-Christian Domingo
Jennifer Grant
Jessica Minion
Paul Van Caeseele
Guillaume Desnoyers
David Haldane
Yang Yu
Xiaofeng Ding
Laura Steven
Jan McFadzen
Courtney Primeau
Irene Martin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To determine invasive group A Streptococcus trends in Canada, we characterized emm1 isolates collected during 2018-2023. The percentage of hypervirulent M1

Indexed as

Streptococcal InfectionsStreptococcus pyogenesAdolescentAdultAgedAged, 80 and overCanadaChildChild, PreschoolFemaleHistory, 21st CenturyHumansInfantInfant, NewbornMaleMiddle Agedantimicrobial resistancebacteriaCanadaemm1group A StreptococcusM1UKscarlet feverStreptococcus pyogenes

Identifiers

PMID39428565
PMCPMC11521172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.